CIK 0001782303 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Boundless Bio, Inc.
Sign in to watch- Ticker
- BOLD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 830751369
- Phone
- (858) 766-9912
- Business address
- 11099 NORTH TORREY PINES ROAD, SUITE 150, LA JOLLA, CA, 92037
- Open-market buys, last 90 days
- $458,375
- in 5 filings
- Open-market sales, last 90 days
- $54,351
- in 1 filing
Net +$404,024. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-08-19 | Abdollahian Neil Chief Business Officer | Grant or award · Stock Option | +19,948 | 19,948 | ||
| 2024-08-19 | Abdollahian Neil Chief Business Officer | Grant or award · Stock Option | +54,871 | 54,871 | ||
| 2024-08-19 | Abdollahian Neil Chief Business Officer | Grant or award · Stock Option | +36,852 | 36,852 | ||
| 2024-08-19 | Abdollahian Neil Chief Business Officer | Grant or award · Stock Option | +23,191 | 23,191 | ||
| 2024-08-19 | Wagner Klaus W. Chief Medical Officer | Returned to the company · Stock Option | −102,564 | 0 | ||
| 2024-08-19 | Wagner Klaus W. Chief Medical Officer | Returned to the company · Stock Option | −9,635 | 0 | ||
| 2024-08-19 | Wagner Klaus W. Chief Medical Officer | Returned to the company · Stock Option | −94,871 | 0 | ||
| 2024-08-19 | Wagner Klaus W. Chief Medical Officer | Returned to the company · Stock Option | −68,080 | 0 | ||
| 2024-08-19 | Wagner Klaus W. Chief Medical Officer | Returned to the company · Stock Option | −41,745 | 0 | ||
| 2024-08-19 | Wagner Klaus W. Chief Medical Officer | Grant or award · Stock Option | +102,564 | 102,564 | ||
| 2024-08-19 | Wagner Klaus W. Chief Medical Officer | Grant or award · Stock Option | +9,635 | 9,635 | ||
| 2024-08-19 | Wagner Klaus W. Chief Medical Officer | Grant or award · Stock Option | +94,871 | 94,871 | ||
| 2024-08-19 | Wagner Klaus W. Chief Medical Officer | Grant or award · Stock Option | +68,080 | 68,080 | ||
| 2024-08-19 | Wagner Klaus W. Chief Medical Officer | Grant or award · Stock Option | +41,745 | 41,745 | ||
| 2024-08-19 | Rubin Jami Chief Financial Officer | Returned to the company · Stock Option | −196,666 | 0 | ||
| 2024-08-19 | Rubin Jami Chief Financial Officer | Returned to the company · Stock Option | −51,420 | 0 | ||
| 2024-08-19 | Rubin Jami Chief Financial Officer | Returned to the company · Stock Option | −32,468 | 0 | ||
| 2024-08-19 | Rubin Jami Chief Financial Officer | Grant or award · Stock Option | +196,666 | 196,666 | ||
| 2024-08-19 | Rubin Jami Chief Financial Officer | Grant or award · Stock Option | +51,420 | 51,420 | ||
| 2024-08-19 | Rubin Jami Chief Financial Officer | Grant or award · Stock Option | +32,468 | 32,468 |
Page 6 of 10 · 185 trades